Skip to content
Faron, etusivu
Releases and publications
Careers
Contact Information
Search for:
LANGUAGE
English
Suomi
About
Management
Board of directors
Scientific Advisory Board
Sustainability
Pipeline
Our science
Clinical trials
Drug candidates
Investors
Faron as an investment
Strategy
Faron’s business
Market overview
Key financials
Analysts
Analysis
Outlook
Share and shareholders
Share information
Shareholders
Share monitor
Management ownership and transactions
Option plans and Warrants
Public offering 2024
AIM rule 26
Governance
Advisors
Articles of association
Auditor
Board committees
General Meeting
Insider management
Remuneration
Risk management and internal control
Reports and presentations
Investor relations
Disclosure policy
Investor calendar
Contact Information
For Patients
About
Management
Board of directors
Scientific Advisory Board
Sustainability
Pipeline
Our science
Clinical trials
Drug candidates
Investors
Faron as an investment
Strategy
Faron’s business
Market overview
Key financials
Analysts
Analysis
Outlook
Share and shareholders
Share information
Shareholders
Share monitor
Management ownership and transactions
Option plans and Warrants
Public offering 2024
AIM rule 26
Governance
Advisors
Articles of association
Auditor
Board committees
General Meeting
Insider management
Remuneration
Risk management and internal control
Reports and presentations
Investor relations
Disclosure policy
Investor calendar
Contact Information
For Patients
Releases and publications
Careers
Contact Information
Search for:
LANGUAGE
English
Suomi
releases and publications
Category
All
Company announcements
Press releases
Managers' transactions
Flagging notifications
Year
All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
02.11.2023
Faron to present data from BEXMAB study at ASH
Regulatory
27.10.2023
Managers’ transactions
Insider Transaction
Regulatory
27.10.2023
Exercise of options
Insider Transaction
Regulatory
27.10.2023
Results of Placing
Regulatory
26.10.2023
Proposed Issue and Placing
Regulatory
11.10.2023
Faron Announces Positive BEXMAB Study Update
Regulatory
03.10.2023
Faron to host webcast on new BEXMAB study data
22.09.2023
Board Changes
Regulatory
22.09.2023
Results of EGM
Regulatory
21.09.2023
Faron Appoints Interim Chief Medical Officer
Regulatory
Previous
Next
Back to top